LAEKNA-B_Providing professional financial news and data related to LAEKNA-B, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

LAEKNA-B (02105.HK): First subject enrolled in Phase I clinical study of LAE118 for advanced solid tumours

Tags：

LAEKNA-B 02105.HK Clinical Trial

2026-09-01

LAEKNA-B (02105.HK): NDA for LAE002 (Afuresertib) Accepted by NMPA for HR+/HER2- Breast Cancer

Tags：

LAEKNA-B 02105.HK R&D Progress

2026-08-12

Laekna-B (02105.HK): Grants Vasque Bio Exclusive License for LAE118 Outside Greater China, Up to USD 517 Million in Milestone Payments

Tags：

LAEKNA-B 02105.HK exclusive global license

2026-06-10

ETF
Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
ETF
Korean Stocks Open Higher but Close Lower as Semiconductor Heavyweights Slip; Csop Kospi 200 Etf (03121.HK) Falls 1.30%
Finance
LAI SUN DEV (00488.HK): Public Float at 19.60%, Still Below 25% Requirement
Finance
BEONE MEDICINES (06160.HK): Grants RSUs Over 52,482 ADSs to 277 Grantees
Finance
BOC AVIATION (02588.HK): Interim Dividend of USD 0.1799 Per Share Equates to HKD 1.411
Finance
MOISELLE INT'L (00130.HK): HKD 15 Million Convertible Bonds Converted, 50 Million New Shares Issued
Finance
WYNN MACAU (01128.HK): Grants Awards Over 317,938 Shares to 315 Employees
Finance
FW FASHION INT (02528.HK): Pop Mart Macau Store Management Arrangement to Terminate
Finance
ASMPT (00522.HK): Independent Non-executive Director Xiao Jieyun Resigns with Effect from 1 January 2027
Finance
SIHUAN PHARM (00460.HK): Five New Specifications of Skin Booster Dongyan Approved for Marketing by NMPA

Scan QR Code

Download App